Skip to main content
. 2021 Jun 4;10(11):2489. doi: 10.3390/jcm10112489

Table 2.

18F-FDG-PET/CT characteristics in 35 AOSD patients.

Abnormal PET/CT 33/35 (94.3%)
Abnormal 18F-FDG Uptake Site Number (%) SUV Available SUVmax,
Mean ± SD
SUVmax,
Range
Bone marrow 26/35 (74.3) 9 6.3 ± 1.9 3.9–9.0
Spleen 17/35 (48.6) 13 4.2 ± 1.5 2.6–7.0
Lymph node
All sites 26/35 (74.3) 24 7.7 ± 3.9 3.3–18.9
Supradiaphragmatic 25/35 (71.4) 23 7.0 ± 3.7 2.7–16.3
Cervical 16/35 (45.7) 12 7.4 ± 3.3 2.8–13.5
Axillary 15/35 (42.9) 13 6.8 ± 4.5 1.6–16.3
Mediastinal 23/35 (65.7) 19 5.7 ± 2.2 2.6–10.7
Infradiaphragmatic 17/35 (48.6) 15 7.0 ± 4.4 2.8–18.9
Abdominal and pelvic 16/35 (45.7) 14 6.6 ± 4.0 2.8–18.9
Inguinal 7/35 (20.0) 4 6.7 ± 5.2 2.4–14.0
Other areas
Joint 3/35 (8.6) 2 6.5 ± 4.7 3.1–9.8
Lung 4/35 (11.4) 1 4.5
Muscle 2/35 (5.7) 1 3.0

Reported in one case only: pleura, pericardium, thyroid cartilage, tonsils, stomach, and colon.